Launched in 2005, Opaldia is a private company backed by significant private equity. It is run by a group of Directors all of whom are appropriately qualified with extensive healthcare and commercial experience in the field of medical genetics, gene profiling, cancer services, screening services, biosciences and healthcare delivery.

If you would like a copy of Opaldia's Statement of Purpose, please write to:

Opaldia Limited, 27 Fitzroy Square, London W1T 6ES, United Kingdom